Abstract:Objective To screen a key molecule, leucine-rich glioma inactivated protein 4 (LGI4), which participates in endothelial cell-mediated osteosarcoma metastasis, and to further analyze its function and molecular mechanism in osteosarcoma metastasis. Methods A co-culture model of human umbilical vein endothelial cells (HUVECs)-osteosarcoma cells was established, and the genes with significant fold change were screened by whole transcriptome sequencing in combination with relevant literature. After, the candidate target gene, LGI4 was verified with real-time quantitative PCR (RT-qPCR) and Western blotting, the expression of LGI4 at mRNA and protein levels was also determined. Osteosarcoma cell line 143B and MTF LGI4 were transfected with the overexpression plasmid of LGI4 to construct the cells with stable overexpression of LGI4. Then the experiments included 5 groups of osteosarcoma cells, including negative control group (normally cultured), co-culture group (co-cultured with HUVECs), co-culture medium group (treated with the HUVECs medium), vector control group (transfected with control plasmid) and LGI4 group (overexpression of LGI4). Transwell assay and wound healing test were used to detect the migration and invasion abilities of osteosarcoma cells. A tumor metastasis model in nude mice was used to verify the effect of LGI4 overexpressed osteosarcoma cells on distant metastasis in vivo. Bioinformatics analysis was applied to analyze the potential downstream target signaling pathways of LGI4, and recovery experiments were performed with related inhibitors to clarify the role of target signaling pathways in the regulation of osteosarcoma metastasis by LGI4. Results The expression levels of LGI4 were markedly decreased in 143B and MTF cells after co-culture with HUVECs (P < 0.05). Compared with the negative control group, the cell migration and invasion abilities of the co-culture group and co-medium group were significantly enhanced, whereas the cell migration and invasion rates of the LGI4 overexpression group were significantly lower than that of the vector control group (P < 0.05). The nude mice metastasis model revealed that the metastasis ability of osteosarcoma cells was suppressed with LGI4 overexpression. Further analysis revealed that NOTCH4 signaling pathway was the downstream target signaling pathway of LGI4, and functional recovery experiments confirmed that LGI4 resulted in osteosarcoma metastasis by inhibiting NOTCH4 signaling pathway (P < 0.05). Conclusion Endothelial cells activate NOTCH4 signaling pathway and thus promote tumor metastasis by inhibiting the expression of LGI4 in osteosarcoma cells.

Nectin-4 promotes osteosarcoma progression and metastasis through activating PI3K/AKT/NF-κB signaling by down-regulation of miR-520c-3p

Interleukin‐1β/nuclear Factor‐κb Signaling Promotes Osteosarcoma Cell Growth Through the Microrna‐181b/phosphatase and Tensin Homolog Axis

MicroRNA-130a Promotes the Metastasis and Epithelial-Mesenchymal Transition of Osteosarcoma by Targeting PTEN.

The TAZ–miR-224–SMAD4 Axis Promotes Tumorigenesis in Osteosarcoma

ACTN4 Promotes the Proliferation, Migration, Metastasis of Osteosarcoma and Enhances Its Invasive Ability Through the NF-κB Pathway

MicroRNA-455-3p Inhibits Osteosarcoma Progression Via HSF1 Downregulation

Figure S4 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

MYLK4 promotes tumor progression through the activation of epidermal growth factor receptor signaling in osteosarcoma

The MiR-193a-5p/NCX2/AKT Axis Promotes Invasion and Metastasis of Osteosarcoma

Endothelial Cells Promote Osteosarcoma Cell Metastasis by Inhibiting LGI4 Expression and Activating NOTCH4 Signaling Pathway

Fibulin-4 Promotes Osteosarcoma Invasion And Metastasis By Inducing Epithelial To Mesenchymal Transition Via The Pi3k/Akt/Mtor Pathway

ACSL4 accelerates osteosarcoma progression via modulating TGF-β/Smad2 signaling pathway

LINC01614 promotes osteosarcoma progression via miR-520a-3p/SNX3 axis

The Downregulation Of Mir-144 Is Associated With The Growth And Invasion Of Osteosarcoma Cells Through The Regulation Of Tagln Expression

LncRNA SNHG4 Promotes Tumour Growth by Sponging Mir-224-3p and Predicts Poor Survival and Recurrence in Human Osteosarcoma

Long Non-Coding RNA Sox4 Promotes Proliferation and Migration by Activating Wnt/β-catenin Signaling Pathway in Osteosarcoma.

Down-regulation of LINC00472 Promotes Osteosarcoma Tumorigenesis by Reducing FOXO1 Expressions Via Mir-300.

Circ_0010220-mediated Mir-503-5p/cdca4 Axis Contributes to Osteosarcoma Progression Tumorigenesis.

Long Noncoding RNA FER1L4 Suppresses Tumorigenesis by Regulating the Expression of PTEN Targeting Mir-18A-5p in Osteosarcoma

MATN4 as a target gene of HIF-1α promotes the proliferation and metastasis of osteosarcoma

NEK6 Promotes the Progression of Osteosarcoma Through Activating STAT3 Signaling Pathway by Down-Regulation of Mir-26A-5p